NSEDisclosure under SEBI Takeover Regulations23 Jun 2026 · 23 Jun 2026, 08:45 pm
Disclosure under SEBI Takeover Regulations
Cohance Lifesciences Limited · COHANCE
✦ AI Summary▲ PositivePledge
Cohance Lifesciences Limited's promoter, Berhyanda Limited, along with persons acting in concert, submitted a disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. They declared that no new encumbrances (pledges) have been created on the company's shares, either directly or indirectly, during the financial year 2025-26. This announcement reassures that only previously disclosed encumbrances exist, indicating stability in the promoter's shareholding pledge status.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment7/10
Full Announcement
Berhyanda Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.